Key Points
- The May 4–8 week represents the peak of the Q1 2026 earnings season, with over 2,500 companies globally expected to report, making it one of the most consequential weeks of the year for investors.
- The S&P 500 is tracking 13.2% year-over-year EPS growth for Q1 2026 — the sixth consecutive quarter of double-digit growth — and FactSet projects that actual growth could reach 19% once the full beat cycle plays out, which would be the strongest quarter since Q4 2021.
- Palantir Technologies (PLTR) kicks off the week Monday after a massive 2025 run; analysts expect Q1 revenue of $1.54B (+60% YoY) as its AI-native government and commercial platform continues to win large contracts.
- Advanced Micro Devices (AMD) reports Tuesday with Q1 revenue estimates of $9.89B, driven by surging MI300X GPU demand for AI data centers — the single most important data center semiconductor print of the week.
- Walt Disney (DIS) delivers its fiscal Q2 2026 results Wednesday, with consensus EPS at $2.18 and streaming profitability and theme park resilience the primary watch items.
- Tesla (TSLA) already reported disappointing Q1 deliveries (358,023 vs. ~370K estimate); now management's update on the Cybercab timeline, FSD commercialization progress, and 2026 delivery guidance are key.
- Arm Holdings (ARM) releases its fiscal Q4 FY2026 results Wednesday after market close, with consensus revenue at $1.47B; AI-driven royalty acceleration from Armv9 architecture adoption is the key watch.
- CoreWeave (CRWV) delivers its second-ever public earnings report Thursday — Q1 2026 consensus revenue estimate is $1.96B — as the AI hyperscaler cloud provider navigates massive CapEx expansion and a rapidly growing backlog.
- Thursday's lineup also includes McDonald's (MCD), MercadoLibre (MELI), Coinbase (COIN), Cloudflare (NET), Howmet Aerospace (HWM), and Shell (SHEL), creating a globally diverse cross-section of earnings signals.
- Toyota Motor (TM) closes the week Friday, offering a critical read on the global auto industry's response to U.S. tariff policy.
Introduction: The Peak of Q1 2026 Earnings Season
As Q2 2026 gets underway, earnings season reaches its apex during the week of May 4–8, when a flood of marquee companies across technology, consumer discretionary, energy, healthcare, financials, and industrial sectors report their Q1 2026 results. The week is loaded with binary risk events — some of the most widely held stocks in global portfolios will deliver numbers that either reinforce or challenge the current bullish consensus.
Context matters heading into this week. According to FactSet, the blended S&P 500 EPS growth rate for Q1 2026 has risen to 13.2% as of late April — the sixth consecutive quarter of double-digit growth and the highest estimated growth rate entering any earnings season since Q2 2022. Of the companies that had reported by late April, approximately 80% beat consensus EPS estimates, in line with the historical 79% average. If the long-run beat pattern holds, FactSet projects actual Q1 growth could reach as high as 19%, which would be the strongest quarterly earnings performance since Q4 2021 at 32%.
Sector leadership is clear: Information Technology is expected to deliver 45%+ EPS growth, Materials 24%, and Financials 15.1%. Healthcare is the notable underperformer at an estimated -9.8% growth, though this is largely attributable to one-time factors. Energy remains a wildcard as crude oil prices have been volatile. Against this constructive backdrop, investors will be watching not just Q1 beats, but Q2 and full-year guidance — because in a world of tariff uncertainty and geopolitical tension, forward visibility is worth more than any single quarter's results.
Monday, May 4
Technology & AI Software
Palantir Technologies (PLTR)
Palantir Technologies (PLTR) opens the week with one of the most-watched reports in AI-native software. The company has evolved dramatically from its intelligence community roots into a diversified AI platform business, anchored by its Artificial Intelligence Platform (AIP) and its Ontology-based operating system for enterprises and governments. The stock has been one of the defining winners of the 2025-2026 AI investment cycle, and each quarterly print is a referendum on whether the growth trajectory is sustainable.
For Q1 2026, consensus estimates place revenue at $1.54B, reflecting approximately 60% year-over-year growth — a remarkable rate for a company at this scale. Analysts project adjusted EPS of $0.32, with EBITDA near $887M and free cash flow around $878M. These are not metrics of a speculative early-stage company: Palantir has been consistently profitable on a GAAP basis and generates strong cash flows. The key question for investors is whether the U.S. commercial segment can maintain its explosive growth pace, which has been propelled by AIP bootcamp-driven enterprise adoption. Government revenues remain the stable foundation, with large defense and intelligence contracts providing multi-year visibility.
The analyst community is cautiously constructive. Wedbush's Dan Ives reiterates an Outperform rating with a $230 target, calling Palantir a "must-own" AI platform. Mizuho's Gregg Moskowitz holds Outperform with a $185 target. DA Davidson's Gil Luria remains Neutral at $180, and Citigroup recently lowered its target to $210 from $260 while maintaining Buy. The average price target across four rated analysts sits at $201.25, reflecting Strong Buy consensus (3 bullish, 1 neutral). Investors will be particularly focused on U.S. commercial revenue growth, remaining deal value (RDV) trends, and any color on international expansion.
View PLTR AI Trading Bot here: NEM, HWM, GE, MU, PLTR - AI Trading Agent (5 Tickers), 15min
Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals (VRTX) reports Monday as one of the most financially sound biotechnology companies in the world. Its cystic fibrosis (CF) franchise — led by the Trikafta/Kaftrio triple-combination therapy — generates near-monopoly-like cash flows, and the company has been actively deploying that cash into next-generation therapies in pain management, kidney disease, and gene editing through its acquisition of Alpine Immune Sciences.
Q1 2026 consensus revenue stands at $2.998B, with net income estimated at $961M. The company does not report a standard diluted EPS consensus in the financials data (it trades at a premium reflecting its cash generation potential), but analysts project EBITDA of approximately $1.33B for the quarter. The CF franchise is the anchor, but Wall Street's attention increasingly turns to suzetrigine (VX-548) for acute pain and the non-opioid positioning story, along with VX-880 for Type 1 diabetes and VX-264 for kidney disease.
Analyst coverage skews bullish. Morgan Stanley's Terence Flynn maintains Overweight with a $612 target — a notably high conviction call. Truist Securities rates VRTX Buy with a $525 target. Canaccord Genuity recently maintained Hold at $437. The consensus is Buy with an average price target of $524.67. Vertex's earnings report matters to the broader biotech sector as a read on specialty pharma pricing power in the current regulatory environment, and any pipeline updates on the pain or kidney franchises could move the stock significantly.
Energy — Midstream & E&P
Williams Companies (WMB)
Williams Companies (WMB) is among the most strategically positioned midstream operators in North America, with its Transco pipeline system serving as the backbone of natural gas transmission along the East Coast. The company has been benefiting from the structural increase in natural gas demand driven by LNG export capacity expansions and AI data center power requirements — both long-duration secular tailwinds.
For Q1 2026, consensus estimates project revenue of $3.27B and EPS of $1.41, with EBITDA of approximately $2.13B. Williams has guided for continued volume growth across its Deepwater Gulf of Mexico gathering assets and expansion projects tied to rising demand. The stable, fee-based nature of its business model insulates it from commodity price swings, making it a compelling utility-like holding for income-oriented investors.
The analyst community is uniformly bullish, with a Strong Buy consensus and an average price target of $83.33. Jefferies' Julien Dumoulin-Smith maintains Buy at $83, RBC Capital's Elvira Scotto holds Outperform at $82, and Scotiabank's Brandon Bingham maintains Sector Outperform at $85. The key metrics to watch include volume throughput on Transco, any updates on new power-generation interconnect projects, and capital allocation — particularly dividend growth and share repurchase activity.
View WMB AI Trading Bot here: WMB / DUG AI Trading Double Agent, 60 min
Diamondback Energy (FANG)
Diamondback Energy (FANG) is one of the most capital-efficient pure-play Permian Basin operators, and its Q1 2026 report arrives in an environment of oil price uncertainty. The company completed its landmark acquisition of Endeavor Energy in 2024, making it the largest pure-play Permian producer by acreage.
Q1 2026 consensus estimates project revenue of approximately $3.93B and EPS of $7.97, with EBITDA near $2.79B. Diamondback's business model is highly sensitive to oil prices, which have experienced significant volatility in early 2026 amid OPEC+ production decisions and tariff-driven macro concerns. However, the company's breakeven costs are among the lowest in U.S. shale, positioning it well even in softer oil price environments.
The analyst community holds a Strong Buy consensus (4 bullish, 1 neutral) with an average price target of $225.20. Wells Fargo's Hanwen Chang maintained Overweight with a target raised to $262 in April 2026, and Morgan Stanley's Devin McDermott holds Overweight at $224. Investors will focus on production volumes, free cash flow generation, the pace of shareholder returns (buybacks and dividends), and any guidance updates reflecting current commodity prices.
View FANG AI Trading Bot here: Energy (OXY, EOG, DVN, FANG, APA, MTDR) - AI Trading Agent with corridor TP 3% / SL 2% (6 Tickers), 60min
Technology — Power Semiconductors
onsemi (ON)
onsemi (ON) reports Monday as an increasingly pivotal semiconductor name in the electric vehicle and industrial power markets. The company has carved out a leading position in silicon carbide (SiC) power semiconductors, which are essential for EV powertrains and industrial motor drives, making its quarterly results a key read on EV supply chain health.
For Q1 2026, consensus revenue is estimated at $1.487B, adjusted EPS at $0.93, and EBITDA around $450M. After a period of inventory correction in 2024, the power semiconductor market appears to be stabilizing, with onsemi's design-win pipeline providing confidence in medium-term recovery. The company's long-term supply agreements (LTSAs) with major EV manufacturers provide revenue visibility, though volume pull-ins and push-outs remain a quarterly variable.
The consensus is Buy (split between 2 bullish and 2 neutral analysts), with an average price target of $74.50. Bank of America's Vivek Arya upgraded onsemi to Buy in April 2026 with an $85 target, citing the inventory trough and improving EV demand visibility. JP Morgan's Harlan Sur and Citigroup's Atif Malik both hold Neutral ratings. Investors will be watching SiC revenue growth, automotive exposure metrics, and guidance for Q2, which will be the first sequential demand signal for the year's second half.
Tuesday, May 5
Technology — Semiconductors & AI Infrastructure
Advanced Micro Devices (AMD)
Advanced Micro Devices (AMD) delivers what may be the single most consequential semiconductor earnings report of the week. The company has emerged as the primary challenger to NVIDIA's dominance in AI accelerators, with its MI300X GPU gaining real traction at major hyperscalers and enterprise cloud customers. The Q1 2026 print will test whether AMD's $7–8B annual AI GPU revenue trajectory is on track or whether execution challenges are emerging.
Q1 2026 consensus revenue is estimated at approximately $9.89B, adjusted EPS at $1.85, and EBITDA around $2.2B. The Data Center segment, encompassing AMD's EPYC CPUs and Instinct GPUs, is expected to be the growth engine. Analysts will be particularly focused on MI300X sell-through data, the ramp timeline for the MI350 and MI400 next-generation accelerators, and any commentary on customer backlog and pricing.
The analyst community holds a Strong Buy consensus (3 bullish, 1 neutral) with an average price target of $333.75. Susquehanna's Christopher Rolland maintained Positive with a target raised to $375 in late April 2026, and DA Davidson's Gil Luria upgraded AMD to Buy at $375. Stifel's Ruben Roy holds Buy at $320, while Bernstein's Stacy Rasgon remains Market Perform at $265, arguing that AI GPU market share capture is already priced in. AMD's earnings call will set the tone for the entire semiconductor sector's second half, making it one of the most market-moving events of the earnings season.
View AMD AI Trading Bot here: Minerals, Electric, Comm Tech, Semi, Oil, Aerospace - AI Trading Agent (25 Tickers), 15min
Arista Networks (ANET)
Arista Networks (ANET) reports Tuesday with a near-perfect analyst consensus and one of the clearest direct exposures to AI infrastructure spending of any networking company. Arista is the dominant supplier of high-speed Ethernet switching for hyperscale data centers, and its platforms are being deployed at scale in AI training and inference clusters at Microsoft, Meta, Google, and others.
Q1 2026 consensus estimates place revenue at $2.619B, adjusted EPS at $0.83, and EBITDA at approximately $1.23B. The company has consistently beaten estimates over recent quarters, and investors will be watching order backlog trends, new AI cluster wins, and commentary on the shift from 400G to 800G and 1.6T Ethernet deployments. Any management color on AI-specific revenue as a percentage of total is highly anticipated.
The analyst consensus is a unanimous Strong Buy (3 of 3 bullish) with an average price target of $188.33. JP Morgan's Samik Chatterjee holds Overweight at $200, Rosenblatt's Mike Genovese recently upgraded to Buy at $180, and Needham's Ryan Koontz reiterates Buy at $185. Arista tends to be a consistent beat-and-raise name, and any upside guidance revision could drive meaningful stock movement.
View ANET AI Trading Bot here: ANET - AI Trading Agent, 15min
Eaton Corporation (ETN)
Eaton Corporation (ETN) is the industrial bellwether for AI-related power infrastructure buildout. The company's electrical segment supplies transformers, switchgear, and uninterruptible power systems — the physical backbone of data centers — making its earnings a direct read on the real-world capex being deployed by hyperscalers and enterprise cloud builders.
Q1 2026 consensus estimates project revenue of approximately $6.5–7B range (the exact figure was not provided in the estimates tool, but full-year 2026 guidance implies strong quarterly figures), with analyst average price target of $384.67. Citigroup's Andrew Kaplowitz maintains Buy with a $464 target, citing data center power demand as a multi-year secular driver. Barclays' Julian Mitchell and Wells Fargo's Joseph O'Dea both hold Equal-Weight ratings with targets around $340–350, reflecting concern about valuation after the stock's significant 2024-2025 run. The Buy consensus (1 bullish, 2 neutral) reflects a divided but broadly constructive Street. Investors will focus on order book trends for electrical equipment, lead times, and any tariff cost commentary given Eaton's complex global supply chain.
View ETN AI Trading Bot here: Energy (BE, CEG), Utilities (PEG), Industrials (ETN, PWR) - AI Trading Agent with corridor TP 3% / SL 2% (5 Tickers), 60min
E-Commerce & Consumer Internet
Shopify (SHOP)
Shopify (SHOP) reports its Q1 2026 results Tuesday as the global commerce platform continues to expand its merchant ecosystem from small businesses to enterprise accounts via the Shopify Plus and Commerce Components offerings. The company's 2025 refocus on pure-play commerce — following the divestiture of its logistics business — appears to be paying dividends in margin expansion.
Q1 2026 consensus estimates project revenue growth toward the $2.3–2.5B range for the quarter, with analysts focusing on Gross Merchandise Volume (GMV), payment attachment rates, and take-rate expansion. The analyst consensus is Buy (2 bullish, 1 neutral) with an average price target of $159.67. Citigroup's Tyler Radke maintains Buy at $163, Wells Fargo's Ken Gawrelski holds Overweight at $166, and Jefferies' Samad Samana remains Hold at $150. Shopify's Q1 results are particularly important given concerns about tariff impacts on cross-border e-commerce — management commentary on international merchant activity will be closely watched.
Healthcare — Pharma & Managed Care
Pfizer (PFE)
Pfizer (PFE) enters its Q1 2026 earnings report in one of the most consequential restructuring periods in its history. After the post-COVID revenue windfall from Paxlovid and Comirnaty, the company has been navigating a brutal correction in its base business while executing an aggressive cost savings program ($4B+ target) and rebuilding its pipeline through the Seagen oncology acquisition.
Q1 2026 consensus estimates project revenue of $13.80B and adjusted EPS of $0.79, with EBITDA around $6.33B. The base business remains pressured by loss of exclusivity risk on key products and declining COVID-related revenues, though Paxlovid has found some floor as an endemic treatment. The Seagen integration and the oncology pipeline — including Padcev and Adcetris — provide the long-term recovery narrative.
The analyst community is cautious. The consensus rating is Hold (0 bullish, 3 neutral, 1 bearish) with a depressed average price target of just $26.75. RBC Capital's Trung Huynh maintains an Underperform rating at $25, while Citigroup and UBS hold Neutral ratings at $27. Morgan Stanley's Terence Flynn maintains Equal-Weight at $28. Investors will scrutinize Paxlovid revenue, signs of pipeline de-risking, and any update on the cost-savings timeline. A guidance raise would be a meaningful positive catalyst.
Technology — Photonics & AI Optics
Lumentum Holdings (LITE)
Lumentum Holdings (LITE) reports its fiscal Q3 FY2026 results Tuesday, as the optical and photonic products company finds itself at the intersection of two powerful secular trends: AI-driven data center interconnect demand and next-generation telecom infrastructure. Lumentum is a leading supplier of transceivers, pump lasers, and 3D sensing components.
Fiscal Q3 FY2026 (ending March 2026) consensus revenue is estimated at approximately $810M, with adjusted EPS of $3.60. The company has been benefiting significantly from hyperscaler demand for 400G and 800G optical transceivers used in AI cluster interconnects. JP Morgan's Samik Chatterjee upgraded Lumentum to Overweight with a $950 target in April 2026, citing accelerating data center optical demand. Morgan Stanley's Meta Marshall maintains Equal-Weight at $710. The consensus is Buy (2 bullish, 1 neutral) with an average price target of $853. Given the recent surge in optical networking stock prices broadly, Lumentum's guidance will be critical for sustaining sector momentum.
View LITE AI Trading Bot here: ASTS, CIEN, LITE - AI Trading Agent (3 Tickers, Communications Technology), 60min
Digital Assets
Strategy (MSTR)
Strategy (MSTR), formerly MicroStrategy, is uniquely positioned in the investment universe as an operating software company with an aggressive Bitcoin treasury strategy that has transformed it into the world's largest corporate holder of Bitcoin. For Q1 2026, investors are less focused on the underlying software business (consensus revenue near $125M) and almost entirely focused on the company's Bitcoin portfolio performance, which is subject to significant fair-value accounting swings under ASC 350-60.
The Q1 2026 net income estimate shows a large implied loss of approximately $11.4B — almost certainly a reflection of Bitcoin fair-value accounting under the unrealized loss framework as Bitcoin prices fluctuated during the quarter. However, the company's long-term bull case centers on its "Bitcoin yield" metric and the accretive nature of its ongoing equity and fixed-income raises used to purchase additional Bitcoin. The analyst consensus is an unusually unanimous Strong Buy (4 of 4 bullish) with an average price target of $268. TD Cowen's Lance Vitanza holds Buy at $350 and Cantor Fitzgerald's Ramsey El-Assal maintains Overweight at $212. For investors, the Q1 report is less about the numbers and more about management's commentary on future Bitcoin accumulation plans, capital raise strategy, and the evolving regulatory environment for corporate crypto holders.
View MSTR AI Trading Bot here: Technology (MSTR, OPEN) - AI Trading Agent with corridor TP 3% / SL 2% (2 Tickers), 60min
Global Banking
HSBC Holdings (HSBC)
HSBC Holdings (HSBC) reports Q1 2026 results Tuesday, offering a global banking perspective from one of the world's largest financial institutions. HSBC's earnings are particularly relevant as a read on Asian banking conditions — especially in Hong Kong and mainland China — as well as the trajectory of net interest margin in a still-elevated global rate environment. The bank has been executing on a strategic simplification under CEO Georges Elhedery, including a divisional restructuring and cost reduction program. Investors will focus on pre-tax profit trends, loan quality in commercial real estate (particularly Hong Kong property), and progress on the Asia-focused strategic pivot.
Wednesday, May 6
Technology — AI Chip Architecture
Arm Holdings (ARM)
Arm Holdings (ARM) reports its fiscal Q4 FY2026 results on Wednesday after the close in what is shaping up to be one of the most significant semiconductor earnings events of the quarter. ARM's business model — licensing chip architectures and collecting royalties on shipped chips — gives it unique exposure to the entire chip ecosystem, from smartphones to data center AI accelerators.
The fiscal Q4 FY2026 (ending March 2026) consensus revenue is estimated at approximately $1.47B, with adjusted EPS of $0.65 and EBITDA of approximately $766M. The prior quarter (Q3 FY2026, reported February 2026) saw revenue of $1.24B, up 26.4% year-over-year, with royalty revenue rising 27% to $737M on surging Armv9 architecture adoption — but diluted EPS of $0.21 missed the $0.41 consensus due to elevated R&D investment. Q4 is expected to show sequential improvement in royalties as Armv9 penetration deepens and AI chips incorporating ARM's architecture for inference workloads ship in volume.
The analyst consensus is Buy (3 bullish, 1 neutral, 1 bearish) with an average target of $187. Wells Fargo's Joe Quatrochi (Overweight, $220), Mizuho's Vijay Rakesh (Outperform, $230), and Susquehanna's Chris Rolland (Positive, $210) are bullish. Morgan Stanley recently downgraded to Equal-Weight at $150. Goldman Sachs' James Schneider maintains a Sell rating at $125, arguing the stock's premium valuation leaves no margin for error. ARM's management commentary on AI chip royalty velocity, the v9 adoption curve, and fiscal 2027 guidance will be the key market-moving elements of this report.
Entertainment & Streaming
The Walt Disney Company (DIS)
The Walt Disney Company (DIS) delivers its fiscal second quarter 2026 (ending March 29, 2026) results Wednesday in one of the highest-profile consumer earnings events of the week. Disney's ongoing streaming-to-profitability transformation — where Disney+ has pivoted from rapid subscriber growth to margin expansion — is entering a new phase, with direct-to-consumer entertainment profitability now established and the company turning its attention to high-quality content investment and theme park capital allocation.
Consensus estimates for fiscal Q2 FY2026 project revenue of $24.83B and adjusted EPS of $2.18, with EBITDA near $5.13B. After years of losses, Disney's streaming segment reached sustained profitability in 2025, and the key watch item for Q2 is whether the combined Disney+/Hulu/ESPN+ bundle is growing subscribers, reducing churn, and expanding ARPU. On the parks side, investors will look for volume trends at domestic and international parks, and any commentary on the massive multi-year park expansion initiative.
The analyst consensus is a unanimous Strong Buy (4 of 4 bullish) with an average price target of $129.50. Barclays' Kannan Venkateshwar holds Overweight at $130, Wells Fargo's Steven Cahall holds Overweight at $148, and Needham's Laura Martin reiterates Buy at $125. Guggenheim's Michael Morris recently maintained Buy at $115. Any upside in streaming margins or theme park volumes could catalyze a meaningful re-rating of Disney's stock, which has lagged since the 2021 highs.
Pharmaceuticals — Obesity & GLP-1
Novo Nordisk (NVO)
Novo Nordisk (NVO) reports Q1 2026 results Wednesday as the Danish pharmaceutical giant navigates a crucial period in the GLP-1 weight loss drug market. After dominating the space with Ozempic and Wegovy, Novo faces increasing competition from Eli Lilly's tirzepatide franchise and a wave of oral GLP-1 entrants in development. The company's stock has corrected meaningfully from its 2024 peak, with Goldman Sachs downgrading to Neutral at a $41 target in March 2026.
The key watch items for Q1 are Wegovy volume growth and gross-to-net pricing trends in the U.S., Ozempic's durability as a diabetes drug amid label competition, and pipeline updates on the company's next-generation obesity candidates. The analyst coverage in our data shows a limited Hold consensus (1 neutral, target $41), reflecting Wall Street's recent recalibration of Novo's growth trajectory. For global investors, Novo Nordisk's Q1 report is a critical read on whether the GLP-1 market is experiencing demand saturation, price pressure, or simply a transition phase ahead of the oral formulation launch cycle.
Technology & AI Applications
Applovin (APP)
Applovin (APP) enters its Q1 2026 earnings report as one of the highest-growth digital advertising and AI platform companies in the market. The company's AXON AI advertising engine has transformed Applovin from a mobile app publisher into a dominant force in mobile performance advertising, and investors are watching closely to see if the company can successfully expand its AI advertising platform beyond gaming into e-commerce and other verticals.
Q1 2026 consensus revenue is estimated at $1.775B, adjusted EPS at $3.61, and EBITDA of approximately $1.49B. These projections reflect extraordinary growth rates for a company of this size. The analyst consensus is a unanimous Strong Buy (4 of 4 bullish) with an average price target of $655. Wells Fargo's Alec Brondolo holds Overweight at $560, Needham's Bernie McTernan reiterates Buy at $700, and Oppenheimer's Martin Yang maintains Outperform at $660. Investors are paying close attention to the software revenue segment, which carries much higher margins than the legacy gaming business, and any update on e-commerce customer acquisition testing would be a major catalyst.
Ride-Sharing & Mobility
Uber Technologies (UBER)
Uber Technologies (UBER) reports Q1 2026 results Wednesday as the global mobility and delivery platform continues to demonstrate the scalability advantages of its dual-sided marketplace. The company has now achieved consistent profitability, and the debate has shifted from "will Uber ever make money?" to "how fast will margins expand?" and "what does autonomous vehicle competition mean for the long-term?"
Q1 2026 consensus revenue is estimated at $13.26B, adjusted EPS at $0.88, and Adjusted EBITDA near $2.44B. Gross bookings growth, driver and rider supply-demand balance, and the Delivery segment's performance are the key financial metrics. The analyst consensus is a unanimous Strong Buy (4 of 4 bullish) with an average price target of $105. Guggenheim's Taylor Manley reiterates Buy at $125, Citizens' Andrew Boone holds Market Outperform at $100, and BTIG's Jake Fuller maintains Buy at $100. Critically, investors will watch for any commentary on the autonomous vehicle partnership landscape — Uber's strategic positioning relative to Waymo and Tesla's robotaxi ambitions is a major long-term narrative.
Healthcare — Pharmacy Benefit & Managed Care
CVS Health (CVS)
CVS Health (CVS) reports Q1 2026 results Wednesday as the diversified healthcare giant continues its multifaceted restructuring. The company's three core segments — Health Care Benefits (Aetna), Health Services (Caremark PBM), and Pharmacy & Consumer Wellness — have each faced distinct pressures, from insurance medical loss ratio challenges to PBM margin compression.
Q1 2026 consensus revenue is estimated at $95.02B — reflecting the massive scale of CVS's pharmacy distribution operations — with adjusted EPS of $3.17 and EBITDA of approximately $5.10B. Critically, CVS is a read on the managed care sector's medical cost trajectory, which has been one of the dominant themes of this earnings season. A strong Q1 Beat and guidance raise at CVS would signal broad industry stabilization.
The analyst consensus is an unusual unanimous Strong Buy (5 of 5 bullish) with an average price target of $94.40. Baird's Michael Ha holds Outperform at $94, Piper Sandler's Jessica Tassan holds Overweight at $99, and Bernstein's Lance Wilkes upgraded to Outperform in March 2026 at $94. B of A's Michael Cherny and Argus Research both maintain Buy ratings. For investors, CVS is the bellwether healthcare print of the week, and any upside in the medical loss ratio trend would have positive read-across implications for UnitedHealth and other managed care names.
Energy — International Integrated
Equinor (EQNR)
Equinor (EQNR) reports Q1 2026 results Wednesday as the Norwegian state-controlled oil major navigates a challenging energy price environment. The company's balanced portfolio of upstream oil and gas, refining, and growing offshore wind assets makes it a useful barometer for integrated energy strategy in a decarbonizing world. The analyst data shows Hold consensus with a $37 target from TD Cowen, reflecting uncertainty about near-term oil price support. Investors will focus on production volumes, realized commodity prices, capital discipline, and any updates on the Empire Wind or other offshore wind project timelines.
Delivery & Logistics
DoorDash (DASH)
DoorDash (DASH) delivers Q1 2026 results Wednesday in a quarter where Marketplace GOV (Gross Order Value) growth, international expansion, and the path to sustained GAAP profitability are the primary investor focus areas. After dominating U.S. food delivery, DoorDash has been aggressively expanding into grocery, alcohol, convenience, and international markets via its Wolt platform in Europe.
Q1 2026 consensus revenue is estimated at $4.15B, with adjusted EBITDA of approximately $742M. The analyst consensus is Buy (2 bullish, 2 neutral) with an average price target of $229.50. BTIG's Jake Fuller holds Buy at $280, Mizuho's Lloyd Walmsley maintains Outperform at $255, while Stifel's Mark Kelley holds at Hold ($185) and Wells Fargo's Ken Gawrelski holds Equal-Weight ($198). Investors will focus on U.S. market share versus Instacart and Uber Eats, Wolt's unit economics in Europe, and the DashPass subscriber trajectory as indicators of long-term platform stickiness.
Alternative Asset Management
Apollo Global Management (APO)
Apollo Global Management (APO) reports Q1 2026 results Wednesday as the alternative asset management sector grapples with a mixed environment — strong credit and private equity fundraising demand, offset by slower deal activity due to interest rate and tariff uncertainty. Apollo's unique combination of asset management and Athene's insurance balance sheet gives it a competitive advantage in the "perpetual capital" model.
Q1 2026 consensus data is not explicitly broken out in the estimate tool, but analysts project full-year 2026 fee-related earnings and spread-related earnings growth. The analyst consensus is a unanimous Strong Buy (5 of 5 bullish) with an average price target of $143. Morgan Stanley's Michael Cyprys holds Overweight at $165, Goldman Sachs' Alexander Blostein holds Buy at $134, and Barclays' Benjamin Budish holds Overweight at $125. Evercore ISI Group's Glenn Schorr maintains Outperform at $145. Investors will watch AUM growth, credit fund deployment velocity, and Athene spread income as the key performance metrics.
Media & Entertainment
Warner Bros. Discovery (WBD)
Warner Bros. Discovery (WBD) enters its Q1 2026 earnings report as a company mid-transformation — still carrying substantial merger-related debt while building out its Max streaming platform, which has been demonstrating solid international expansion and domestic engagement metrics. The company's decision to split into two separate entities (a streaming and studios company vs. a linear networks and sports company) is a major structural event that investors are tracking closely.
Investors will be focused on Max subscriber growth, studios revenue from any major theatrical releases, the linear TV advertising and affiliate fee environment, and progress on debt reduction. The analyst consensus and estimates data show WBD as a mixed-consensus name with limited coverage in our data; the company remains a high-risk, high-reward proposition given its leverage profile and the success-or-failure binary of the Max platform strategy.
Quantum Computing
IonQ (IONQ)
IonQ (IONQ) reports Q1 2026 results Wednesday in what will be a landmark print for the publicly traded quantum computing sector. The company surpassed $100 million in annual revenue for 2025 — the first publicly traded quantum computing company to achieve this milestone — reporting $130 million in full-year 2025 revenue, up 202% year over year. For Q1 2026, management guided revenue between $48 million and $51 million; the Zacks consensus stands at approximately $49.7 million, representing 556% year-over-year growth.
IonQ has guided for 2026 full-year revenue between $225 million and $245 million, with its Adjusted EBITDA loss projected at $310–$330 million as it scales operations and integrates acquisitions. The company has been expanding its quantum-as-a-service offering across commercial and government sectors, recently launching a quantum-safe network in Florida and participating in DARPA's HARQ program. Consensus EPS for the quarter projects a loss of approximately $0.47 per share. IonQ's report is less about quarterly profitability and more about commercialization progress, bookings trajectory, and any new enterprise or government contract wins that de-risk the 2026 annual revenue target.
Thursday, May 7
Energy — International Majors
Shell (SHEL)
Shell (SHEL) kicks off Thursday's slate with its Q1 2026 results, reporting as one of the world's largest integrated energy companies in a period of crude oil price volatility. Shell's diversified portfolio — spanning upstream oil and gas, LNG, chemicals, refining, and renewables — provides relative resilience compared to pure-play E&P companies, but earnings remain highly sensitive to commodity prices.
Analysts project Q1 2026 EPS and revenue consistent with moderate oil price environment assumptions. The analyst consensus is Strong Buy (3 bullish, 1 neutral) with an average price target of $108. Scotiabank's Betty Zhang holds Sector Outperform at $122, TD Cowen's Jason Gabelman maintains Buy at $110, and Piper Sandler's Ryan Todd holds Overweight at $106. Wells Fargo's Sam Margolin remains Equal-Weight at $94. Key watch items include LNG trading margins (one of Shell's most profitable segments), refinery utilization, Integrated Gas volumes, and any update on Shell's capital allocation between buybacks and energy transition investments.
Consumer — Quick Service Restaurants
McDonald's Corporation (MCD)
McDonald's Corporation (MCD) reports Q1 2026 results Thursday as the global quick-service restaurant bellwether. The company has been executing a value-driven recovery strategy after experiencing notable same-store sales softness in 2024 and 2025, when consumer trade-down behavior and food safety concerns weighed on traffic. The "$5 Meal Deal" and other value platforms appear to be driving recovery in domestic comparable sales.
Q1 2026 consensus estimates project revenue of $6.47B and adjusted EPS of $3.53, with EBITDA of approximately $3.44B. Global comparable sales growth — the single most important metric — will be scrutinized across U.S., International Operated Markets (IOM), and International Developmental Licensed (IDL) segments. The analyst consensus is Buy (3 bullish, 2 neutral) with an average price target of $348. BTIG's Peter Saleh reiterates Buy at $370, Keybanc's Christopher Carril holds Overweight at $345, and Morgan Stanley's Brian Harbour maintains Equal-Weight at $334. Rothschild recently upgraded from Sell to Neutral at $306. Any inflection in global comparable sales growth would be received positively across the restaurant sector broadly.
Life Sciences
Gilead Sciences (GILD)
Gilead Sciences (GILD) reports Q1 2026 results Thursday as the company continues its evolution from an HIV-focused franchise to a broader oncology and antiviral platform. Gilead's Biktarvy HIV treatment remains the global market share leader and continues to grow, while the oncology pipeline — centered on Trodelvy for breast and bladder cancers and the CAR-T therapies Yescarta and Tecartus — represents the long-term growth catalyst.
Q1 2026 consensus revenue is estimated at approximately $6.925B, with net income near $1.94B. The analyst consensus is a unanimous Strong Buy (3 of 3 bullish) with an average price target of $170. Citigroup's Geoff Meacham maintains Buy at $165, Morgan Stanley's Matthew Harrison holds Overweight at $175, and Needham's Joseph Stringer reiterates Buy at $170. Watch items include Biktarvy volume and pricing trends in the U.S. and international markets, Trodelvy penetration in breast cancer, and any pipeline update on lenacapavir, the long-acting HIV injectable that could be a franchise-changing product over the next decade.
Healthcare Distribution
McKesson Corporation (MCK)
McKesson Corporation (MCK) reports its fiscal Q4 FY2026 (ending March 2026) results Thursday as the leading pharmaceutical distributor in North America. The company's distribution-at-scale model generates predictable cash flows tied to prescription volume growth, specialty drug penetration, and manufacturer price increases — making it one of the most reliable earnings compounders in healthcare.
Fiscal Q4 FY2026 consensus revenue is estimated at $101.38B — reflecting the enormous throughput of McKesson's pharma distribution operations — with adjusted EPS of $12.92 and EBITDA near $1.89B. The analyst consensus is a unanimous Strong Buy (4 of 4 bullish) with an average price target of $1,000. UBS's Kevin Caliendo maintains Buy at $1,000, Barclays' Glen Santangelo holds Overweight at $1,050, and Evercore ISI Group's Elizabeth Anderson maintains Outperform at $950. Key metrics include specialty distribution revenue (oncology), segment operating profit margins, and full-year FY2027 guidance. Any raise to EPS guidance would confirm McKesson's status as a premier defensive compounder.
Energy — Canadian Oil Sands
Canadian Natural Resources (CNQ)
Canadian Natural Resources (CNQ) reports Q1 2026 results Thursday as one of Canada's largest oil sands operators. The company's long-life, low-decline oil sands assets generate significant and durable free cash flow, supporting an aggressive shareholder return program. CNQ has been a consistent dividend grower and has deployed substantial capital into share buybacks.
The analyst consensus is Strong Buy (2 of 2 bullish) with an average price target of $57. Goldman Sachs' Neil Mehta holds Buy at $49, and RBC Capital's Greg Pardy maintains Outperform at $65. Watch items include oil sands production volumes, synthetic crude realizations, operating costs per barrel, and the trajectory of the capital return program — particularly given lower oil prices in early 2026.
Aerospace — Precision Components
Howmet Aerospace (HWM)
Howmet Aerospace (HWM) is one of the most compelling pure-play aerospace earnings stories this week. The company manufactures precision casting and engineered fasteners for commercial and defense aircraft engines, making its revenues almost directly proportional to aircraft production rates and MRO (maintenance, repair, and overhaul) activity. With Boeing and Airbus both ramping production, Howmet has rare multi-year forward visibility.
Q1 2026 consensus revenue is estimated at $2.242B, adjusted EPS at $1.28, and EBITDA at approximately $685M. The analyst consensus is a unanimous Strong Buy (4 of 4 bullish) with an average price target of $286.50. RBC Capital's Ken Herbert holds Outperform at $300, B of A's Ronald Epstein holds Buy at $300, BTIG's Andre Madrid reiterates Buy at $275, and Citigroup's John Godyn holds Buy at $271. With aerospace production backlogs extending years into the future, Howmet represents one of the most visible earnings growth profiles in the industrial sector.
View HWM AI Trading Bot here: Aerospace HWM - AI Trading Agent, 5min
Latin American E-Commerce & Fintech
MercadoLibre (MELI)
MercadoLibre (MELI) reports Q1 2026 results Thursday as the undisputed leader in Latin American e-commerce and digital financial services. The company's dual-flywheel model — Mercado Libre marketplace + Mercado Pago fintech — has been compounding at extraordinary rates across Brazil, Mexico, Argentina, and Colombia, driven by rising internet penetration, increasing formalization of commerce, and digital payments adoption.
Q1 2026 consensus revenue is estimated at approximately $8.32B, with adjusted EPS at $13.89 and EBITDA near $871M. These represent significant year-over-year growth, reflecting the combination of operational leverage and robust GMV expansion. The analyst consensus is Strong Buy (4 bullish, 1 neutral) with an average price target of $2,380. Barclays' Trevor Young holds Overweight at $2,500, BTIG's Marvin Fong reiterates Buy at $2,400, Cantor Fitzgerald's Deepak Mathivanan holds Overweight at $2,350, and Jefferies' Alex Wright recently upgraded to Buy at $2,600. UBS's Kaio Prato recently downgraded to Neutral at $2,050, citing FX headwinds and Brazil macro risks. The key metrics are Total Payment Volume (TPV) for Mercado Pago, GMV growth by market, credit portfolio quality, and EBIT margins by segment.
Travel & Short-Term Rentals
Airbnb (ABNB)
Airbnb (ABNB) reports Q1 2026 results Thursday in what is typically the company's seasonally weakest quarter. Q1 represents the inter-seasonal period between holiday travel and summer bookings, making it an important test of whether Airbnb's demand base has become truly year-round rather than peaking in summer.
Q1 2026 consensus estimates project revenue of $2.619B, adjusted EPS of $0.86, and adjusted EBITDA of approximately $484M. Nights booked, Average Daily Rate (ADR), and the performance of Airbnb's "experiences" and "rooms" product expansions are the key metrics. The analyst consensus is Buy (2 bullish, 2 neutral) with an average price target of $161.25. Wells Fargo's Ken Gawrelski recently upgraded to Overweight at $178, Tigress Financial's Ivan Feinseth holds Buy at $185, while UBS's Stephen Ju maintains Neutral at $153. Any evidence of ADR resilience or new market penetration in Asia and Latin America would be a positive catalyst.
Consumer Beverages
Monster Beverage (MNST)
Monster Beverage (MNST) reports Q1 2026 results Thursday as the dominant independent energy drink company navigates competitive pressure from Red Bull, Prime Energy, and emerging entrants, while also executing geographic expansion through its Coca-Cola distribution partnership. The company's Reign Total Body Fuel and Reign Storm brands address different consumer occasions, and international expansion continues to be the primary growth lever.
Q1 2026 consensus estimates project revenue of $2.161B, adjusted EPS of $0.56, and EBITDA of approximately $683M. The analyst consensus is Strong Buy (3 bullish, 1 neutral) with an average price target of $86.25. Stifel's Matthew Smith maintains Buy at $90, Wells Fargo's Chris Carey holds Overweight at $85, and Deutsche Bank's Steve Powers holds Buy at $90. UBS's Peter Grom maintains Neutral at $80. Watch items include U.S. convenience store scan data trends, international market volume growth, and gross margin progression given aluminum can cost dynamics.
Cybersecurity & Network Infrastructure
Cloudflare (NET)
Cloudflare (NET) reports Q1 2026 results Thursday as the global network security and content delivery platform continues its rapid expansion from a network infrastructure provider into a comprehensive security service edge (SSE) and AI gateway platform. The company's ability to sell "network as a service" to enterprises — replacing legacy VPN, firewalls, and CDN infrastructure — is the defining growth narrative.
Q1 2026 consensus revenue is estimated at $622.6M, with adjusted EPS of $0.41, though net income is expected to remain slightly negative at approximately -$37.8M as the company invests in its AI product suite. The analyst consensus is Strong Buy (3 bullish, 1 neutral) with an average price target of $236.75. Piper Sandler's James Fish recently upgraded to Overweight at $222, Mizuho's Gregg Moskowitz holds Outperform at $235, and Citigroup's Fatima Boolani maintains Buy at $265. Net Revenue Retention (NRR), customer count for large contracts ($100K+ ARR), and adoption rates for Cloudflare One (the SASE offering) and AI Gateway products are the critical metrics for this report.
AI Cloud Infrastructure
CoreWeave (CRWV)
CoreWeave (CRWV) delivers its second-ever public earnings report Thursday in one of the most closely watched tech events of the week. The company, which went public on Nasdaq in March 2025, describes itself as "The Essential Cloud for AI" — a GPU-focused cloud provider built from the ground up to serve the computational demands of AI training and inference at scale.
Q1 2026 consensus revenue is estimated at approximately $1.96B, with EBITDA of approximately $1.16B — remarkable numbers for a company that launched its IPO just over a year ago. Revenue is expected to grow sequentially and dramatically year-over-year, driven by long-term contracted capacity commitments from Microsoft (which has committed several billion dollars annually to CoreWeave) and a growing roster of AI startup and enterprise customers. However, the company is simultaneously burning massive amounts of capital on infrastructure: consensus free cash flow for Q1 shows approximately -$6.18B, reflecting the intense GPU server and data center buildout required to serve signed contracts.
The analyst consensus is Strong Buy (3 bullish, 1 neutral) with an average price target of $136.75. Oppenheimer's Param Singh maintains Outperform at $150, Wells Fargo's Michael Turrin holds Overweight at $135, and Cantor Fitzgerald's Brett Knoblauch maintains Overweight at $156. Barclays' Raimo Lenschow holds Equal-Weight at $106. Additionally, CoreWeave recently priced $1B in 9.75% senior notes due 2031, signaling continued aggressive capital structure activity. Investors want to see backlog, contracted revenue, and customer diversification — particularly any evidence of revenue sources beyond Microsoft. The full-year 2026 revenue guidance raise (or lack thereof) will be the most important single data point.
Cryptocurrency Exchange
Coinbase Global (COIN)
Coinbase Global (COIN) reports Q1 2026 results Thursday in a quarter characterized by significant cryptocurrency market volatility. Coinbase's revenue is heavily tied to crypto asset prices and trading volumes, with Bitcoin and Ethereum price levels directly influencing retail and institutional transaction revenue.
Q1 2026 consensus revenue is estimated at approximately $1.50B, with net income estimated near breakeven (-$13.9M consensus) and EBITDA of approximately $424M. The results will reflect whatever Bitcoin and Ethereum price trajectories occurred in Q1 2026. Analyst consensus is Buy (3 bullish, 1 neutral, 1 bearish) with an average price target of $251. Cantor Fitzgerald's Ramsey El-Assal holds Overweight at $250, Bernstein's Gautam Chhugani maintains Outperform at $330, and Citizens' Devin Ryan holds Market Outperform at $355. Barclays' Benjamin Budish recently downgraded to Underweight at $140. Watch items include the Base layer-2 blockchain transaction revenue, institutional prime brokerage growth, and any update on Coinbase's regulatory engagement with the SEC under the current administration.
Semiconductors — Microcontrollers
Microchip Technology (MCHP)
Microchip Technology (MCHP) reports its fiscal Q4 FY2026 (ending March 2026) results Thursday as the embedded microcontroller and analog chip company works through a prolonged inventory correction cycle that has pressured its financials through 2024-2025. The company's products are widely used in automotive, industrial, and IoT applications.
Fiscal Q4 FY2026 consensus estimates project revenue of approximately $1.262B, adjusted EPS of $0.80, and EBITDA near $447M. The analyst consensus is Buy (split: 2 bullish, 2 neutral) with an average price target of $81.25. JP Morgan's Harlan Sur holds Overweight at $95, Citigroup's Christopher Danely holds Buy at $91, Truist's William Stein maintains Hold at $69, and Wells Fargo's Joe Quatrochi holds Equal-Weight at $70. The key watch items are the channel inventory normalization progress, lead times, and any green shoots in customer orders — specifically from automotive and industrial markets that have been the most depressed segments. Any guidance raise indicating a recovery path would likely drive a sharp stock reaction.
Satellite Communications
EchoStar (SATS)
EchoStar (SATS) reports Q1 2026 results Thursday. EchoStar has been reorganized through significant financial restructuring following its debt restructuring, with Dish TV continuing to decline in subscriber count while the Hughes satellite broadband service remains the company's most valuable remaining asset. Q1 2026 consensus revenue is estimated at approximately $3.63B, with EBITDA near $488M, but the company's net income is projected at approximately -$87M as it continues to work through its balance sheet challenges. The analyst consensus is Buy (split: 1 bullish, 2 neutral) with an average price target of $135.33. Investors will focus on the Hughes subscriber trajectory, satellite capacity utilization, and the strategic direction under its restructured corporate framework.
AI Infrastructure — Bitcoin Mining & HPC
Iris Energy (IREN)
Iris Energy (IREN) reports Q1 2026 results Thursday as a data center operator that straddles the Bitcoin mining and high-performance computing (HPC/AI) sectors. Iris Energy has been one of the more aggressive pivots in the mining space, shifting capacity toward GPU-based AI cloud computing to capture higher-margin workloads than proof-of-work Bitcoin mining. The company's analyst consensus is a unanimous Strong Buy (4 of 4 bullish) with an average price target of $70.25, reflecting high conviction in the HPC pivot story.
Optical Components — AI Connectivity
Applied Optoelectronics (AAOI)
Applied Optoelectronics (AAOI) reports Q1 2026 results Thursday as a manufacturer of optical networking components and subsystems, with a focus on transceivers for data center interconnects and fiber-to-the-home (FTTH) applications. The company has experienced explosive growth in data center-related optical demand tied to AI infrastructure buildout. Q1 2026 consensus revenue is estimated at approximately $154.8M with a modest net loss, as the company invests in scaling capacity to meet strong demand. The analyst consensus is Buy (2 bullish, 1 neutral) with an average price target of $91.33. Rosenblatt's Mike Genovese maintains Buy at $140, reflecting aggressive optimism about the data center transceiver demand cycle.
Friday, May 8
Global Automotive
Toyota Motor Corporation (TM)
Toyota Motor Corporation (TM) closes the week Friday with its fiscal Q4 FY2026 (ending March 2026) earnings, and the report carries outsized geopolitical significance in 2026. As the world's largest automaker by volume, Toyota's results are a critical read on the intersection of three major forces: U.S. tariff policy on imported vehicles, yen-dollar exchange rate dynamics, and the global EV transition's pace relative to hybrid vehicle demand.
Toyota has been vocal about the impact of U.S. tariffs on Japanese automakers. The 25% import tariff imposed in early 2026 on foreign-assembled vehicles directly affects Toyota's Camry, RAV4, and other popular models imported from Japanese plants. The company has some offset from its U.S. manufacturing in Texas, Indiana, Kentucky, and Mississippi, but full production localization takes years. Any updated financial impact disclosure will be closely monitored.
The analyst coverage in our data reflects a Hold consensus (1 neutral, $221 target) from Freedom Broker, reflecting the unresolved nature of tariff negotiations and yen volatility. However, Toyota's hybrid vehicle dominance — the Prius, Camry Hybrid, and RAV4 Hybrid — positions it uniquely as consumers globally seek fuel efficiency without the range-anxiety concerns of pure EVs. Investors will focus on operating profit (which is highly yen-denominated), global production volumes, and any revised fiscal 2027 guidance that incorporates the tariff impact.
Energy — Canadian Pipeline Infrastructure
Enbridge (ENB)
Enbridge (ENB) closes the week Friday with its Q1 2026 results, reporting as North America's largest energy infrastructure company by transported volume. Enbridge's network of crude oil pipelines, natural gas pipelines, and utility-scale natural gas distribution assets generates highly predictable, long-term contracted fee-based cash flows — making it one of the most stable income-generating securities in the energy sector.
The company's strategic expansion into U.S. natural gas utilities (through the acquisitions of Questar, East Ohio Gas, and Tri Global Energy assets) has further diversified its revenue base and is expected to drive utility-rate-like earnings growth for years. The analyst consensus is Strong Buy (1 of 1 bullish) with a price target of $76 from RBC Capital's Maurice Choy, who maintains Outperform. The company is expected to report Q1 results consistent with its guided EBITDA range, with investors focused on the utility acquisition integration progress, Line 3 and Line 5 right-of-way developments, and dividend sustainability. With a yield that remains among the highest in Canadian infrastructure, Enbridge's quarterly print is particularly significant for income-oriented investors.
This article is prepared for informational purposes as an earnings preview. All estimates are Wall Street consensus figures and do not represent guaranteed outcomes. Investors should conduct their own due diligence before making investment decisions.
Tickeron AI Perspective